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Renal hemodynamic and tubular responses to salt in women
using oral contraceptives.
Background. The use of oral contraceptives is associated
with an increased risk of developing hypertension but the mecha-
nisms of this hypertensive effect are not completely defined.
The purpose of the present study was to assess prospectively
the systemic and renal hemodynamic and tubular responses to
salt in women taking oral contraceptives.
Methods. Twenty seven young healthy normotensive women
taking oral contraceptives containing monophasic combination
of 30 g ethynilestradiol and 150 g desogestrel for6 months
were enrolled. All women were assigned at random to receive
a low (40 mmol/day) or a high (250 mmol/day) sodium diet
for 1 week on two consecutive menstrual cycles during the
active oral contraceptive phase. At the end of each diet period,
24-hour ambulatory blood pressure, renal hemodynamics, so-
dium handling, and hormonal profile were measured.
Results. The blood pressure response to salt on oral contra-
ceptives was characterized by a salt-resistant pattern with a
normal circadian rhythm. Salt loading results in an increase in
glomerular filtration rate (GFR) (P  0.05 vs. low salt), with
no change in the renal plasma flow, thus leading to an increase
in the filtration fraction (P 0.05). At the tubular level, women
on oral contraceptives responded to a low salt intake with a
marked increased in proximal sodium conservation (P  0.01
vs. high salt) and with an almost complete reabsorption of
sodium reaching the distal tubule. After sodium loading, both
the proximal and the distal reabsorption of sodium decreased
significantly (P  0.01).
Conclusion. The use of oral contraceptives is not associated
with an increased blood pressure response to salt in young
normotensive women. However, oral contraceptives affect the
renal hemodynamic response to salt, a high salt intake leading
to an increase in GFR and filtration fraction. This effect is possibly
mediated by the estrogen-induced activation of the renin-angio-
tensin system. Oral contraceptives also appear to increase the
tubular responsiveness to changes in sodium intake. Taken
together, these data point out evidence that synthetic sex ste-
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roids have a significant impact on renal function in women.
The renal effects of oral contraceptives should be taken into
account when managing young women with renal diseases.
The use of oral contraceptives is known to increase
blood pressure in a large proportion of women and is
associated with an increased risk of developing hyperten-
sion [1, 2]. The mechanisms whereby oral contraceptives
trigger a blood pressure elevation are not well under-
stood. In early studies, elevated plasma levels of renin
and angiotensinogen were found in women receiving es-
trogens [3–5]. It was concluded from these observations
that the renin-angiotensin system plays a major role in
mediating the changes in blood pressure in oral contra-
ceptive users. However, similar increases in angioten-
sinogen were measured in both normotensive and hyper-
tensive women taking oral contraceptives, suggesting
that the hepatic stimulation of angiotensinogen by estro-
gens is probably not the only determinant of the change
in blood pressure [6, 7]. An impaired negative feedback
on renin secretion induced by oral contraceptives repre-
sents another mechanism that could lead to the rise in
blood pressure in hypertensive women receiving oral
contraceptives [8]. Yet, a more recent study failed to
confirm that the renin-angiotensin system plays a promi-
nent role in maintaining a high blood pressure in women
with oral contraceptive–associated hypertension [9].
Sodium retention is yet another potential mechanism
whereby oral contraceptives could lead to an increase
in blood pressure. In Dahl salt-sensitive rats, female sex
hormones appear to protect against the development
of sodium-dependent and -independent hypertension as
ovariectomized Dahl salt-sensitive rats exhibit an exag-
gerated development of hypertension [10, 11]. In humans,
the incidence of hypertension clearly increases in post-
menopausal females, when female sex hormones decrease
[12] and this may again be related to a greater sodium
retention. Indeed, we have reported recently that meno-
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pausal women not on hormonal replacement therapy are
salt-sensitive, their blood pressure increasing signifi-
cantly on high salt diet [abstract; Peche`re-Bertschi A
et al, J Am Soc Nephrol 10:369, 1999].
This contrasts markedly with nonmenopausal women
who are rather salt-resistant whatever the phase of the
menstrual cycle [13]. The relative contribution of estro-
gens and progesterone in mediating these various re-
sponses to salt in nonmenopausal and menopausal
women is still unclear because the direct effects of female
sex hormones on renal sodium handling have not been
investigated in great details. Several studies have demon-
strated that progesterone is natriuretic but the effects of
endogenous as well as exogenous estrogens on sodium
excretion are not clearly defined. Ribstein et al [9] have
recently suggested that there is an altered autoregulation
of renal sodium handling in hypertensive women taking
oral contraceptives. However, women included in this
study were not investigated under different salt diets.
Thus, whether oral contraceptives affect the blood pres-
sure by influencing the renal response to salt is still un-
known.
The goals of the present study were therefore to inves-
tigate prospectively the blood pressure and the renal he-
modynamic and tubular responses to salt in young nor-
motensive healthy women taking oral contraceptives using
a standard protocol that has been used previously in
noncontraceptive users [13, 14].
METHODS
Subjects
The study population consisted of 27 young white nor-
motensive female volunteers recruited mostly among the
medical students and the hospital staff of the University
Hospital of Geneva. All women were healthy and had
been on oral contraceptives containing 30 g ethyniles-
tradiol plus 150 g desogestrel for 6 months. They
were nonsmokers and were not taking any medication
known to affect blood pressure and renal function. At
the initial visit, a full medical history and a clinical exami-
nation were undertaken. The volunteers were randomly
assigned to be studied at the beginning (day 4 to day
12) and at the end (day 21 to day 28) of the treatment
cycles. The study protocol has been reviewed and ap-
proved by the Institutional Ethics Committee (Univer-
sity Hospital, Geneva) and all subjects gave their written
informed consent.
Clinical investigation
The volunteers were randomly allocated to receive a
low (40 mmol sodium per day) and a high (250 mmol
sodium per day, achieved by adding 6 g of salt in their
usual diet) sodium diet for a 7-day period during two
consecutive months. The diets were conducted at home
and all women received detailed recommendations on
how to follow a low salt diet. After each 7-day diet
period, 24-hour urines were collected separately during
the day (from 8:00 a.m. to 10:00 p.m.) and during the
night (from 10:00 p.m. to 8:00 a.m.) in order to measure
sodium excretion. Concomitantly, 24-hour blood pres-
sure was recorded using ambulatory blood pressure mon-
itoring (Diasys, Physicor, Geneva, Switzerland). This
device has been validated by the British Hypertension
Society and was rated B/A. Ambulatory blood pressure
was measured at 20-minute intervals during the day
(from 8:00 a.m. to 10:00 p.m.) and every 60 minutes
during the night (from 10:00 p.m. to 8:00 a.m.). On the
next day, the volunteers were admitted to the hospital
at 8:30 a.m. after an overnight fast to measure their renal
function. Renal hemodynamics was measured using sin-
istrin (an analog of inulin) and paraaminohippuric acid
(PAH) clearances as described previously [15]. After
lying quietly for a 90-minute period of equilibration in
supine position and administration of an oral water load
of 5 mL/kg to ensure a stable urine output, the glomeru-
lar filtration rate (GFR), and the effective renal plasma
flow (ERPF) were measured twice, in two 90-minute
clearance intervals.
Analytic procedures
Sodium excretion was expressed as UNa·V in mmol/
day or mol/min, where UNa is the urinary sodium con-
centration and V is the urinary volume expressed either
in mL/24 hours or in mL/min. Proximal renal sodium
handling was assessed by the determination of endoge-
nous lithium in plasma and urine using graphite furnace
atomic absorption spectrophotometry [16, 17] and by
the fractional excretion of lithium and sodium using the
standard formula (FEX  clearance of x divided by the
GFR). In addition, the fractional distal reabsorption of
sodium (i.e., the percentage of the distally delivered so-
dium reabsorbed in the postproximal nephron segments)
was calculated as [(FELi  FENa)/FELi] · 100. Plasma
catecholamines were determined by high-performance
liquid chromatography [18] and plasma renin activity
(PRA) and aldosterone by radioimmunoassay [19, 20].
Plasma progesterone levels were measured using an en-
zyme immunoassay (Kryptor, CIS Bio, Saclay, France).
Sinistrin (Inutest) was purchased from Laevosan Ge-
sellschaft (Zu¨rich, Switzerland) and PAH from SERB,
Laboratoires Pharmaceutiques (Paris, France).
Statistics
All results are expressed as mean  standard error
(SEM). Data were then analyzed using a paired or un-
paired Student t test for independent samples when ap-
propriate. A one-way analysis of variance was used for
comparison between oral contraceptive users and non-
users.
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Table 1. Characteristics of oral contraception users (N  27)
Age years 26 (range, 20–40)
Family history of hypertension 14/27
Weight kg 58.51.5
Body mass index kg/m2 20.80.5
Premenstrual symptoms 20/27
Cycle study day 5.30.3 (range, 4–12, N  13)
150.4 (range, 14–21, N  14)a
Oral contraceptives Ethinylestradiol 30 g 
desogestrel 150 g
Serum creatinine lmol/L 762
a Thirteen women were studied during the first week of taking oral contracep-
tives and 14 women were studied during the third week of the treatment. The
results were exactly of the same magnitude, which is why the two groups were
pooled.
Values are mean  SE.
Table 2. Ambulatory blood pressure response to salt
on oral contraceptives
Day Night
Sodium diet Low High Low High
Systolic blood pressure mm Hg 1072 1082 912a 932a
Diastolic blood pressure mm Hg 731 711 592a 601a
Pulse pressure mm Hg 341 372 322 331a
Heart rate beats/min 842 802 642a 672a
aP  0.01 vs. daytime
Values are meanSE.
RESULTS
The baseline characteristics of the women included in
this study are presented in Table 1. More than half of
the subjects suffered from mild premenstrual symptoms.
There was a family history of hypertension in about half
of the volunteers.
Blood pressure and heart rate response to salt
The changes in 24-hour urinary sodium excretion in-
duced by the two diets were significantly different. On
a low salt diet, UNa·V was 26  3 mmol/24 hours, and
on a high salt diet, the mean sodium excretion was 322
20 mmol/24 hours (P  0.01). The salt-induced changes
in daytime and nighttime ambulatory blood pressure,
heart rate, and pulse pressure on oral contraceptives
are presented in Table 2. No significant differences in
daytime or nocturnal ambulatory blood pressure or heart
rate were observed on high compared with low sodium
intake on oral contraceptives. A significant nocturnal dip
in both systolic and diastolic blood pressures was found
whatever the diet (P  0.01 nighttime compared with
daytime). Figure 1 illustrates the pressure-natriuresis re-
lationship in subjects on oral contraceptives in compari-
son with women not receiving contraceptives and evalu-
ated either during the follicular or during the luteal phase
of a normal menstrual cycle. The graph demonstrates
that blood pressure on oral contraceptives is essentially
salt-resistant, as found in the two phases of the normal
menstrual cycle without oral contraceptives [13].
Fig. 1. Relationship between mean ambulatory blood pressure
(mm Hg) and sodium excretion (mol/min) in normotensive women
studied on oral contraceptive agents and in oral contraceptive nonusers.
All values are mean  SE.
Table 3. Renal hemodynamic and hormonal responses to salt
on oral contraceptives
Sodium diet
Low High
GFR mL/min/1.73 m2 964 1174a
ERPF mL/min/1.73 m2 44618 48519
FF % 221 240.5a
PRA ng/mL/hour 2.80.3 1.00.1b
Aldosterone nmol/L 0.60.2 0.10.02b
Adrenaline nmol/L 0.30.2 0.30.1
Noradrenaline nmol/L 2.00.5 1.50.3
Progesterone ng/mL 0.40.1 0.50.1
Abbreviations are: GFR, glomerular filtration rate; ERPF, effective renal
plasma flow; FF, filtration fraction; PRA, plasma renin activity.
aP  0.05; bP  0.01 vs. low salt diet
Values are meanSE.
Renal hemodynamic and hormonal response to salt
The effects of changing the sodium intake on renal
hemodynamics and hormonal profile on oral contracep-
tives are presented in Table 3. Salt loading induced a
significant increase in GFR (P 0.05) and no significant
change in ERPF compared with low salt intake, conse-
quently filtration fraction was significantly increased
(P  0.05). The effects of changing sodium intake on
the vasoactive hormones profile in oral contraceptive
users are also presented in Table 3. As expected, PRA
and aldosterone levels decreased significantly (P 0.01)
after sodium loading. Plasma noradrenaline and adrena-
line levels were not significantly changed by the different
sodium diets. On oral contraceptives, plasma progester-
one levels were low and not affected by the sodium
content of the diet.
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Table 4. Segmental tubular renal sodium response to salt on oral
contraceptives (N  27)
Sodium diet
Low High
Body weight kg 58.31.4 59.71.5a
Urinary volume L
Day 1.30.1 1.30.1
Night 0.40.05b 0.40.03b
UNa · V lmol/min
Day 172 16812c
Night 184 1288b,c
FENa %
Day 0.120.02 1.010.06c
Night 0.140.03 0.880.07c
ClLi mL/min
Day 14.91.4 25.72.7c
Night 12.81.2 21.01.9c
FELi %
Day 14.01.4 21.52c
Night 13.81.3 19.41.7c
FDRNa %
Day 99.10.1 94.70.4c
Night 99.00.2 94.90.4c
FEK %
Day 16.10.9 12.00.9c
Night 8.90.7 5.00.34c
Abbreviations are: U, urinary; FENa, fractional excretion of sodium; Cl, clear-
ance; FELi, fractional excretion of lithium; FDRNa, fractional distal reabsorption
of sodium; K, potassium.
aP  0.05; bP  0.01 daytime vs. nighttime; cP  0.01 vs. low salt diet
Values are meanSE.
Segmental renal sodium handling on oral
contraceptives and the effect of salt
On oral contraceptives, administration of high sodium
diet caused a significant increase in body weight ( 1.4
0.2 kg). Table 4 shows the diet-induced changes in so-
dium excretion and proximal and distal renal sodium
handling. The urinary volume did not change signifi-
cantly from a low to a high salt diet. As expected from
the diets, the daytime and nighttime urinary sodium ex-
cretion increased significantly from a low to a high so-
dium intake (P  0.01), indicating that compliance to
the regimen was excellent. On a high salt diet, sodium
excretion decreased significantly during the night (P 
0.01, day vs. night). The fractional excretion of endoge-
nous lithium (FELi), a marker of proximal excretion, in-
creased significantly on a high sodium diet (P  0.01),
and the fractional distal reabsorption of sodium (FDRNa)
decreased significantly, indicating that sodium balance
is maintained by both a decrease in proximal and distal
sodium reabsorption in women on oral contraceptives.
DISCUSSION
The main objective of the present study was to evalu-
ate the effect of oral contraceptives on the blood pressure
and the renal response to salt. Our results show that the
blood pressure response to salt in young normotensive
women on oral contraceptives is characterized by a salt-
resistant pattern, with a normal circadian rhythm. In
the kidney, chronic salt loading results in a significant
increase in GFR with no change in ERPF, thus leading
to an increase in filtration fraction. At the tubular level,
women on oral contraceptives respond to a low salt in-
take with increased proximal sodium conservation and
with an almost complete reabsorption of the sodium
reaching the distal level of the tubule. After sodium
loading, both the proximal and the distal reabsorption
of sodium decreases significantly.
The administration of oral contraceptives has been
associated with a rise in blood pressure and some women
may even develop a significant but reversible hyperten-
sion [1, 2]. Activation of the renin-angiotensin system is
generally considered as the main factor leading to the
increase in blood pressure since estradiol administration
stimulates the hepatic synthesis of angiotensinogen [21,
22]. The exogenous female sex hormones can also cause
a decrease in sodium excretion accompanied by water
retention, two factors that may further contribute to
increase blood pressure [23]. In this study, we show for
the first time that the pressure-natriuresis relationship of
women taking oral contraceptives is of the salt-resistant
pattern, as it is in oral contraceptive nonusers in both
phases of the menstrual cycle [13] (Fig. 1). Interestingly,
the salt-resistant pattern is observed despite the relative
stimulation of the renin-angiotensin system. As expected,
PRA in our oral contraceptive users is higher than the
activity measured in oral contraceptive nonusers studied
at comparable levels of salt intake [13] and the changes
in PRA induced by the changes in sodium intake is sig-
nificantly greater in oral contraceptive users than in non-
users as shown in Table 5. Yet, in oral contraceptive
users, PRA can still be partially suppressed on a high salt
intake. The salt-resistant pattern in face of an activated
renin-angiotensin system is therefore in accordance with
the findings of Hall et al [23] who have shown in dogs
that salt sensitivity develops primarily when the activity
of the renin-angiotensin cascade cannot be modulated.
The results of the present study suggest that exogenous
female sex hormones influence markedly the renal he-
modynamic response to salt without affecting systemic
blood pressure. Indeed, salt loading in oral contraceptive
users induced a significant increase in GFR with no
change in ERPF, hence filtration fraction increased. The
salt-induced changes in GFR and ERPF are shown in
Table 5 for oral contraceptive users and nonusers. A
comparable but nonsignificant trend was observed in
oral contraceptive nonusers studied during the follicular
phase [14]. In contrast, during the luteal phase of the
normal menstrual cycle, we found that salt loading in-
duces a renal vasodilatation with no change in GFR.
There are few data on the renal hemodynamic effects
of oral contraceptives. An early study by Hollenberg et
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Table 5. Renal response to salt: Comparison between oral contraceptive users and nonusersa
Oral contraceptive Follicular Luteal
(N  27) (N  17) (N  18)
Sodium diet High-low High-low High-low ANOVA
GFR mL/min/1.73 m2 226 4.93.9 1.66b P  0.009
ERPF mL/min/1.73 m2 2823 530 6436c P  NS
PRA ng/mL/hour 1.90.3 0.830.16b 0.760.21b P  0.007
FENa % 0.890.05 1.160.13 0.970.1 P  0.06
FELi % 7.92.3 12.17.1 1.22.2d P  0.06
Abbreviations are: GFR, glomerular filtration rate; ERPF, effective renal plasma flow; PRA, plasma renin activity.
aAll values have been obtained by subtracting the result of the low salt diet from that of the high salt diet.
bP  0.01 vs. oral contraceptive (unpaired t test); cP  0.05; dP  0.01 vs. follicular (paired t test)
Values are meanSE.
al [24] showed that oral contraceptives in healthy young
women reduced the ERPF and reported a negative cor-
relation between plasma angiotensin II levels and ERPF
with a significant activation of the renin-angiotensin sys-
tem. The administration of oral contraceptives has been
found to increase creatinine clearance in young women
studied on a free sodium intake [25]. Kang et al [26]
found significant increases in systolic blood pressure,
renal vascular resistance, and filtration fraction in oral
contraceptive users compared to nonusers, and showed
that these differences were at least partially abolished
by angiotensin II blockade. At the glomerular level, an
increase in GFR and filtration fraction can result either
from a vasodilatation of afferent arterioles associated or
not with an increase in the tonus of the efferent arteriole
or to a vasoconstriction of the efferent arteriole with
no change in the afferent tone. A direct effect on the
glomerulus may also produce an increase in filtration
fraction. To explain the salt-induced renal vasodilatation
and fall in filtration fraction in women studied during
the luteal phase, we had proposed the hypothesis that
estrogens modulate the renal hemodynamics indirectly
via the nitric oxide pathway and perhaps prostaglandin
formation [13, 14], thereby inhibiting the effects of angio-
tensin II on glomerular hemodynamics. Through this
mechanism, estrogens could cause a renal vasodilatation
and a decrease in filtration fraction. The same mecha-
nism may actually be operating to explain the salt-
induced increase in GFR in oral contraceptive users but
with one important difference (i.e., the baseline activity
of the renin-angiotensin system). Thus, we hypothesize
that the vasodilatory effect of estrogens in oral contra-
ceptive users may be more prominent at the level of
afferent arteriole, thereby leading to an increase in GFR
and filtration fraction. Of course, we realize that this
hypothesis is very speculative and deserves further inves-
tigations with more direct measurements. Of note, high
plasma estrogen levels have been reported to augment
endothelial nitric oxide synthesis [27, 28].
The apparent difference between endogenous and ex-
ogenous female sex hormones as reflected by the more
pronounced effect of salt loading on renal hemodynamic
in oral contraceptive users than in nonusers could be
attributed to differences in potency between endogenous
and exogenous female sex hormones. Indeed, combined
oral contraceptive agents deliver pharmacologic levels
of estrogens that exhibit 6 to 10 times the estrogenic
activity provided by endogenous estrogens [29]. Finally,
the observation of a salt-induced increase in GFR and
filtration fraction in oral contraceptive users may have
a long-term clinical impact and implications for use in
patients with renal disease. Indeed, in a recent study, a
significant increase in 24-hour urinary albumin excretion
was found in normotensive as well as in hypertensive
women using oral contraceptives when compared with
nonusers with a similar blood pressure [9]. In this clinical
situation, a low sodium intake may lower intraglomerular
pressure and hence reduce urinary protein excretion.
The effects of exogenous female sex hormones on
renal tubular function are not known. Endogenous pro-
gesterone is known to be natriuretic, but synthetic deriv-
atives of progesterone may not have similar natriuretic
properties. Indeed, early studies have demonstrated that
synthetic progestins had a decreased affinity for renal
mineralocorticoid receptors, explaining a lack of natri-
uretic activity of these compounds [30]. Whether estro-
gen affects tubular sodium handling is not known. In our
oral contraceptive users, the tubular response to changes
in sodium intake was relatively comparable to that ob-
tained in normotensive men [31] and in women studied
during the follicular phase of the menstrual cycle (Table
5) [14]. Indeed, the proximal reabsorption of sodium
increased markedly on a low sodium diet, as reflected
by a decrease in FELi, and decreased significantly on a
high sodium diet. As shown in Figure 2, the FELi/FENa
relationship is parallel but shifted to lower levels of FELi
in women receiving oral contraceptives when compared
to women studied in the follicular phase. This shift may
again be attributed to the activation of the renin-angio-
tensin system leading to an increased proximal reabsorp-
tion of sodium. A high reabsorption of sodium was also
found to occur in the distal tubule as reflected by the
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Fig. 2. Salt-induced variations in daytime fractional excretion of so-
dium (FENa) and endogenous lithium (FELi) in normotensive women
studied on oral contraceptives. For comparison, the same parameters
studied in the follicular and luteal phases of the normal menstrual cycle
published previously are presented [14]. Low salt, 40 mmol/day; high
salt, 250 mmol/day.
very high FDRNa. Thus, combined oral contraceptives
do not appear to affect the balance between the proximal
and the distal nephron segments. However, because of
the activation of the renin-angiotensin system, women
on oral contraceptives may have a greater tubular re-
sponsiveness. Interestingly, in our study, chronic oral
contraceptive administration resulted in a positive so-
dium balance when diet changes from a low to a high
salt diet, reflected in a mean weight gain of 1.5 kg.
CONCLUSION
This study shows that the use of hormonal contracep-
tives is not associated with an increased blood pressure
response to salt, and women on oral contraceptives have
a salt-resistant pattern like oral contraceptive nonusers.
However, oral contraceptives do affect the renal hemo-
dynamic response to salt, an effect that appears to be
mediated by the combined effects of estrogens on the
renin-angiotensin system and on vasodilatory factors
such as nitric oxide and prostaglandins. The increase in
filtration fraction observed with the administration of
contraceptives in women receiving a high salt diet may
be of clinical concern since a high filtration fraction has
been associated with an increased incidence of micro-
albuminuria and proteinuria as well as with an increased
risk of glomerular sclerosis. At last, exogenous female
sex hormones appear to increase the tubular respon-
siveness to changes in sodium intake leading to an in-
creased reabsorption of sodium. Taken together, these
data point out evidence that synthetic sex steroids differ
in their effects on kidney from endogenous steroids. In
a general point of view, it implicates that in women on
oral contraceptives suffering from any kidney problem,
sodium restriction should be encouraged.
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